fulvestrant
- Product NDC
- 70534-002
- 11-digit product format
- 705340002
- Labeler code
- 70534
- Product ID
- 70534-002_1c0edab9-ab70-46ac-8262-851e910c49db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fulvestrant
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR
- Labeler
- HBT Labs, Inc.
- Application
- ANDA209714
- Marketing category
- ANDA
- Marketing start
- 2019-11-21
- Marketing end
- 0000-00-00
- Substance
- FULVESTRANT
- Active strength
- 50 mg/mL
- Pharmacologic classes
- Estrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70534-002-01 | 70534000201 | 2 SYRINGE, GLASS in 1 CARTON (70534-002-01) > 5 mL in 1 SYRINGE, GLASS | 2019-11-21 | 0000-00-00 | No | No | Current |